Wyeth To Make Decision On Redux Settlement Amendment Next Week
This article was originally published in The Pink Sheet Daily
Executive Summary
Wyeth will decide the week of Jan. 10 whether to accept an amendment to the Redux class action settlement that covers claimants with less serious medical conditions, CEO Robert Essner said
You may also be interested in...
Wyeth Wins Round One Of 5,000 In Hormone Therapy Suits
Research findings about breast cancer risk from Premarin are mixed, Wyeth maintains.
Wyeth Wins Round One Of 5,000 In Hormone Therapy Suits
Research findings about breast cancer risk from Premarin are mixed, Wyeth maintains.
Wyeth Accepts Redux Settlement Amendment
Wyeth has agreed to an amendment to the Redux class action settlement that covers claimants with less serious medical conditions, the company said Jan. 10